Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - dimethyl fumarate, quantity: 240 mg - capsule, enteric - excipient ingredients: croscarmellose sodium; gelatin; purified talc; magnesium stearate; iron oxide yellow; silicified microcrystalline cellulose; triethyl citrate; titanium dioxide; brilliant blue fcf; methacrylic acid copolymer; colloidal anhydrous silica; iron oxide black; methacrylic acid - ethyl acrylate copolymer (1:1); propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; purified water; shellac; strong ammonia solution; potassium hydroxide - dimethyl fumarate enteric coated capsules are indicated in patients with relapsing multiple sclerosis to reduce the frequency of relapses and to delay the progression of disability.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - dimethyl fumarate, quantity: 120 mg - capsule, enteric - excipient ingredients: croscarmellose sodium; gelatin; purified talc; magnesium stearate; iron oxide yellow; silicified microcrystalline cellulose; triethyl citrate; titanium dioxide; brilliant blue fcf; methacrylic acid copolymer; colloidal anhydrous silica; iron oxide black; methacrylic acid - ethyl acrylate copolymer (1:1); propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; purified water; shellac; strong ammonia solution; potassium hydroxide - dimethyl fumarate enteric coated capsules are indicated in patients with relapsing multiple sclerosis to reduce the frequency of relapses and to delay the progression of disability.

Australia - English - Department of Health (Therapeutic Goods Administration)

pharmacor pty ltd - dimethyl fumarate, quantity: 240 mg - capsule, enteric - excipient ingredients: magnesium stearate; methacrylic acid copolymer; triethyl citrate; silicified microcrystalline cellulose; purified talc; croscarmellose sodium; colloidal anhydrous silica; titanium dioxide; indigo carmine; purified water; iron oxide yellow; gelatin; polysorbate 80; sodium lauryl sulfate - it is indicated in patients with relapsing multiple sclerosis to reduce the frequency of relapses and to delay the progression of disability.

Australia - English - Department of Health (Therapeutic Goods Administration)

pharmacor pty ltd - dimethyl fumarate, quantity: 240 mg - capsule, enteric - excipient ingredients: croscarmellose sodium; triethyl citrate; silicified microcrystalline cellulose; methacrylic acid copolymer; magnesium stearate; colloidal anhydrous silica; purified talc; titanium dioxide; indigo carmine; purified water; iron oxide yellow; gelatin; polysorbate 80; sodium lauryl sulfate - it is indicated in patients with relapsing multiple sclerosis to reduce the frequency of relapses and to delay the progression of disability.

Australia - English - Department of Health (Therapeutic Goods Administration)

pharmacor pty ltd - dimethyl fumarate, quantity: 120 mg - capsule, enteric - excipient ingredients: silicified microcrystalline cellulose; triethyl citrate; croscarmellose sodium; magnesium stearate; purified talc; methacrylic acid copolymer; colloidal anhydrous silica; titanium dioxide; indigo carmine; purified water; iron oxide yellow; gelatin; polysorbate 80; sodium lauryl sulfate - it is indicated in patients with relapsing multiple sclerosis to reduce the frequency of relapses and to delay the progression of disability.

Australia - English - Department of Health (Therapeutic Goods Administration)

pharmacor pty ltd - dimethyl fumarate, quantity: 120 mg - capsule, enteric - excipient ingredients: magnesium stearate; methacrylic acid copolymer; silicified microcrystalline cellulose; purified talc; croscarmellose sodium; colloidal anhydrous silica; triethyl citrate; titanium dioxide; indigo carmine; purified water; iron oxide yellow; gelatin; polysorbate 80; sodium lauryl sulfate - it is indicated in patients with relapsing multiple sclerosis to reduce the frequency of relapses and to delay the progression of disability.

Australia - English - Department of Health (Therapeutic Goods Administration)

pharmacor pty ltd - dimethyl fumarate, quantity: 120 mg - capsule, enteric - excipient ingredients: croscarmellose sodium; magnesium stearate; methacrylic acid copolymer; triethyl citrate; purified talc; silicified microcrystalline cellulose; colloidal anhydrous silica; titanium dioxide; indigo carmine; purified water; iron oxide yellow; gelatin; polysorbate 80; sodium lauryl sulfate - it is indicated in patients with relapsing multiple sclerosis to reduce the frequency of relapses and to delay the progression of disability.

Australia - English - Department of Health (Therapeutic Goods Administration)

pharmacor pty ltd - dimethyl fumarate, quantity: 240 mg - capsule, enteric - excipient ingredients: methacrylic acid copolymer; purified talc; silicified microcrystalline cellulose; triethyl citrate; colloidal anhydrous silica; croscarmellose sodium; magnesium stearate; titanium dioxide; indigo carmine; purified water; iron oxide yellow; gelatin; polysorbate 80; sodium lauryl sulfate - it is indicated in patients with relapsing multiple sclerosis to reduce the frequency of relapses and to delay the progression of disability.

Australia - English - Department of Health (Therapeutic Goods Administration)

accelagen pty ltd - dimethyl fumarate, quantity: 240 mg - capsule, enteric - excipient ingredients: magnesium stearate; titanium dioxide; croscarmellose sodium; microcrystalline cellulose; methacrylic acid copolymer; colloidal anhydrous silica; triethyl citrate; methacrylic acid - ethyl acrylate copolymer (1:1); gelatin; purified talc; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; purified water; shellac; strong ammonia solution; iron oxide black; potassium hydroxide - dimethyl fumarate msn is indicated in patients with relapsing multiple sclerosis to reduce the frequency of relapses and to delay the progression of disability.

Australia - English - Department of Health (Therapeutic Goods Administration)

accelagen pty ltd - dimethyl fumarate, quantity: 120 mg - capsule, enteric - excipient ingredients: purified talc; microcrystalline cellulose; gelatin; croscarmellose sodium; titanium dioxide; triethyl citrate; colloidal anhydrous silica; magnesium stearate; methacrylic acid copolymer; methacrylic acid - ethyl acrylate copolymer (1:1); propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; purified water; shellac; strong ammonia solution; iron oxide black; potassium hydroxide - dimethyl fumarate msn is indicated in patients with relapsing multiple sclerosis to reduce the frequency of relapses and to delay the progression of disability.